Frailty assessed using the Liver Frailty Index^TM (LFI) is a risk factor for mortality in patients with advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab

Philippe Sultanik, Claudia Campani, Sarah Mouri, Eleonore Spitzer, Mathilde Wagner, Lorraine Blaise, Marie Lequoy, Violaine Ozenne, Jean Charles Nault, Dominique Thabut, Nathalie Ganne-Carrié, Manon Allaire